One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Lateral Flow Assay Market

[ 英語タイトル ] Lateral Flow Assay Market by Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Multiplex, Sandwich), End User - Global Forecast to 2022


Product Code : MNMHC00108626
Survey : MarketsandMarkets
Publish On : February, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

“The global lateral flow assay market projected to grow at a CAGR of 8.2%.”
The global lateral flow assay market is projected to reach USD 8.24 billion by 2022, growing at a CAGR of 8.2% from 2017 to 2022. Factor such as the high prevalence of infectious diseases across the globe, rapidly increasing geriatric population, increasing usage of home-based lateral flow assay devices, and growing demand for point-of-care testing are fueling the growth of the market. However, reluctance towards changing existing diagnostic practices, the implementation of excise duty on medical devices, and stringent & time-consuming regulatory policies are restricting market growth to a certain extent.

“The lateral flow readers segment is expected to register the highest CAGR during the forecast period.”
On the basis of product, the lateral flow assay market is segmented into kits & reagents and lateral flow readers. The lateral flow readers segment is expected to register the highest CAGR during the forecast period. The high growth in this segment is attributed to the growing awareness about digital/mobile readers, technological advancements, and higher accuracy offered by these readers.

“Food safety and environmental testing are expected to grow at the highest CAGR during 2017 to 2022.”
Based on application, the lateral flow assay market is segmented into clinical/point-of-care testing, veterinary diagnostics, food safety and environmental testing, and drug development & quality control testing. The food safety and environmental testing segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is driven by the shifting of the food & beverage industry from lab-based conventional microbiology techniques to rapid lateral flow assay tests.

“APAC is projected to witness the highest growth during the forecast period.”
North America held the largest share of the global lateral flow assay market in 2016. On the other hand, the Asia-Pacific region is expected to witness the highest CAGR during the forecast period, owing to the rapidly developing healthcare industry in China and India, growth in aging population, rising life expectancy, rising per capita income, increasing investments in the region by key market players, the expansion of private-sector hospitals & clinics to rural areas, the availability of low-cost labor for manufacturing, presence of a favorable regulatory environment, and growing demand for home and POC testing.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–41%, Tier 2–29% and Tier 3–30%
• By Designation – C-level–34%, Director Level–38%, Others–28%
• By Region – North America–31%, Europe–33%, Asia-Pacific–19%, Latin America–10%, Middle East & Africa–7%

Some of the major market players in the lateral flow assay market are Alere, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Siemens AG (Germany), Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Johnson & Johnson (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN N.V. (Netherlands), and PerkinElmer, Inc. (U.S.).
Research Coverage:
The report analyzes the various types of kits & reagents and their adoption pattern. It aims at estimating the market size and future growth potential of the global lateral flow assay market for different segments such as product, application, technique, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global lateral flow assay market. The report analyzes the global lateral flow assay market by product, application, technique, end user, and region
• Product Development/Innovation: Detailed insights on upcoming trends and new product launches in the global lateral flow assay market
• Market Development: Comprehensive information on the lucrative emerging regions by product, application, technique, end user, and region
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global lateral flow assay market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the global lateral flow assay market

TABLE OF CONTENTS

1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKET DEFINITION 21
1.3 MARKET SCOPE 22
1.3.1 MARKETS COVERED 22
1.3.2 YEARS CONSIDERED FOR THE STUDY 23
1.4 CURRENCY 23
1.5 LIMITATIONS 23
1.6 STAKEHOLDERS 23
2 RESEARCH METHODOLOGY 24
2.1 RESEARCH APPROACH 24
2.1.1 SECONDARY SOURCES 26
2.1.1.1 Key data from secondary sources 26
2.1.2 PRIMARY SOURCES 27
2.1.2.1 Key data from primary sources 27
2.1.2.2 Breakdown of primaries 28
2.1.2.3 Key industry insights 28
2.2 MARKET SIZE ESTIMATION 29
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 31
2.4 MARKET SHARE ESTIMATION 32
2.5 ASSUMPTIONS FOR THE STUDY 32
3 EXECUTIVE SUMMARY 33
4 PREMIUM INSIGHTS 38
4.1 LATERAL FLOW ASSAYS: MARKET OVERVIEW 38
4.2 LATERAL FLOW ASSAYS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 39
4.3 GEOGRAPHIC SNAPSHOT: LATERAL FLOW ASSAYS MARKET, 2016 40
4.4 GEOGRAPHIC MIX: LATERAL FLOW ASSAYS MARKET 41
4.5 ASIA-PACIFIC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION 42
5 MARKET OVERVIEW 43
5.1 INTRODUCTION 43
5.2 MARKET DYNAMICS 43
5.2.1 MARKET DRIVERS 44
5.2.1.1 High prevalence of infectious diseases across the globe 44
5.2.1.2 Rapidly increasing geriatric population 46

5.2.1.3 Growing usage of home-based lateral flow assay devices 47
5.2.1.4 Growing demand for point-of-care testing 47
5.2.2 MARKET RESTRAINTS 48
5.2.2.1 Reluctance towards changing existing diagnostic practices 48
5.2.2.2 Implementation of excise duty on medical devices by the U.S. Government 48
5.2.2.3 Stringent and time-consuming regulatory policies 49
5.2.3 MARKET OPPORTUNITIES 49
5.2.3.1 Growing applications of lateral flow assay tests in clinical diagnostics 49
5.2.3.2 Increasing applications of lateral flow point-of-need assays 50
5.2.3.3 Rising demand for lateral flow assays in the food & beverage industry 50
5.2.4 CHALLENGES 51
5.2.4.1 Limited reimbursements for lateral flow assay products 51
6 INDUSTRY INSIGHTS 52
6.1 INTRODUCTION 52
6.2 INDUSTRY TRENDS 52
6.2.1 INTEGRATION OF MICROFLUIDICS TECHNOLOGY IN LATERAL FLOW ASSAYS 52
6.2.2 DEMAND FOR QUANTITATIVE RESULTS 53
6.2.3 RISING DEMAND FOR MULTIPLEXED LATERAL FLOW BIOSENSORS 53
6.3 REGULATORY ANALYSIS 54
6.3.1 NORTH AMERICA 54
6.3.2 EUROPE 55
6.3.3 ASIA 56
6.3.3.1 India 56
6.3.3.2 China 56
6.3.3.3 Japan 56
6.4 VALUE CHAIN ANALYSIS 57
6.5 SUPPLY CHAIN ANALYSIS 58
7 GLOBAL LATERAL FLOW ASSAYS MARKET, BY PRODUCT 60
7.1 INTRODUCTION 61
7.2 KITS & REAGENTS 63
7.3 LATERAL FLOW READERS 64
7.3.1 DIGITAL/MOBILE READERS 65
7.3.2 BENCHTOP READERS 67
8 GLOBAL LATERAL FLOW ASSAYS MARKET, BY TECHNIQUE 68
8.1 INTRODUCTION 69
8.2 SANDWICH ASSAYS 70
8.3 COMPETITIVE ASSAYS 71
8.4 MULTIPLEX DETECTION ASSAYS 72
9 GLOBAL LATERAL FLOW ASSAY MARKET, BY APPLICATION 73
9.1 INTRODUCTION 74
9.2 CLINICAL/POINT-OF-CARE TESTING 75
9.2.1 INFECTIOUS DISEASE TESTING 77
9.2.1.1 Mosquito-borne disease testing 79
9.2.1.2 Influenza testing 80
9.2.1.3 Sexually transmitted infections 81
9.2.1.4 Hepatitis 83
9.2.1.5 Tuberculosis 84
9.2.1.6 Other infectious diseases 85
9.2.2 CARDIAC MARKER TESTING 86
9.2.3 PREGNANCY & FERTILITY TESTING 87
9.2.3.1 Pregnancy testing 89
9.2.3.2 Fertility testing 90
9.2.4 CHOLESTEROL/LIPID TESTING 91
9.2.5 DRUGS-OF-ABUSE TESTING 92
9.2.6 OTHER TESTS 93
9.3 VETERINARY DIAGNOSTICS 94
9.4 FOOD SAFETY & ENVIRONMENT TESTING 96
9.5 DRUG DEVELOPMENT & QUALITY TESTING 97
10 GLOBAL LATERAL FLOW ASSAYS MARKET, BY END USER 98
10.1 INTRODUCTION 99
10.2 HOSPITALS AND CLINICS 100
10.3 HOME CARE 102
10.4 DIAGNOSTIC LABORATORIES 103
10.5 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 104
10.6 OTHER END USERS 105
11 LATERAL FLOW ASSAY MARKET, BY REGION 107
11.1 INTRODUCTION 108
11.2 NORTH AMERICA 109
11.2.1 U.S. 115
11.2.2 CANADA 120
11.3 EUROPE 125
11.3.1 GERMANY 131
11.3.2 FRANCE 136
11.3.3 U.K. 140
11.3.4 ITALY 145
11.3.5 SPAIN 149
11.3.6 REST OF EUROPE 154

11.4 ASIA-PACIFIC 158
11.4.1 JAPAN 163
11.4.2 CHINA 167
11.4.3 INDIA 172
11.4.4 REST OF ASIA-PACIFIC 176
11.5 LATIN AMERICA 180
11.5.1 BRAZIL 184
11.5.2 MEXICO 189
11.5.3 REST OF LATIN AMERICA 193
11.6 MIDDLE EAST & AFRICA 197
12 COMPETITIVE LANDSCAPE 202
12.1 INTRODUCTION 202
12.2 MARKET SHARE ANALYSIS 202
12.3 COMPETITIVE LEADERSHIP MAPPING 204
12.3.1 VISIONARY LEADERS 204
12.3.2 INNOVATORS 204
12.3.3 DYNAMIC DIFFERENTIATORS 204
12.3.4 EMERGING COMPANIES 204
12.4 COMPETITIVE BENCHMARKING 206
12.4.1 STRENGTH OF PRODUCT PORTFOLIO (25 PLAYERS) 206
12.4.2 BUSINESS STRATEGY EXCELLENCE (25 PLAYERS) 207
*Top 25 companies analysed for this study are - Alere Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Siemens AG (Germany), Johnson & Johnson (U.S.), Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (U.S.), Abbott Laboratories (U.S.), Hologic, Inc. (U.S.), Merck Millipore (U.S.), Quidel Corporation (U.S.), Abcam plc. (U.S.), DCN Diagnostics (U.S.), Surmodics, Inc. (U.S.), BioPorto Diagnostics A/S (Denmark), Chembio Diagnostic Systems, Inc. (U.S.), Polysciences, Inc. (U.S.), Innova Biosciences Ltd. (U.K.), Microcoat Biotechnologie GmbH (Germany), Senova GmbH (Germany), Scienion AG (Germany)
13 COMPANY PROFILES 208
(Overview, Strength of Product Portfolio Business Strategy Excellence Products Offering, Recent Development’s, Business Strategy)*
13.1 ALERE INC. 208
13.2 F. HOFFMANN-LA ROCHE AG 213
13.3 DANAHER CORPORATION 217
13.4 SIEMENS AG 221
13.5 JOHNSON & JOHNSON 226
13.6 BECTON, DICKINSON AND COMPANY 230
13.7 BIOMÉRIEUX SA 234
13.8 BIO-RAD LABORATORIES, INC. 239
13.9 THERMO FISHER SCIENTIFIC INC. 243
13.10 QIAGEN N.V. 249
13.11 PERKINELMER INC. 253
13.12 ABBOTT LABORATORIES 258
13.13 HOLOGIC, INC. 262
13.14 QUIDEL CORPORATION 266
*Details on Overview, Strength of Product Portfolio Business Strategy Excellence Products Offering, Recent Development’s, Business Strategy might not be captured in case of unlisted companies.
14 APPENDIX 271
14.1 INSIGHTS OF INDUSTRY EXPERTS 271
14.2 DISCUSSION GUIDE 272
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 277
14.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 279
14.5 AVAILABLE CUSTOMIZATIONS 281
14.6 RELATED REPORTS 282
14.7 AUTHOR DETAILS 283

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+